6533b870fe1ef96bd12d0567

RESEARCH PRODUCT

MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms

C A HansonDomenica CaramazzaSergio SiragusaTerra L. LashoNaseema GangatAnimesh PardananiChristy FinkeA TefferiMrinal M. Patnaik

subject

MaleCancer Researchmedicine.medical_specialtyGenotypejak2 mpl mutation myeloprolifertaive neoplasmPolymerase Chain ReactionPolymorphism Single NucleotideSettore MED/15 - Malattie Del SangueMyeloproliferative DisordersPolymorphism (computer science)hemic and lymphatic diseasesInternal medicineGenotypemedicineHumansGeneticsThrombopoietin receptorHematologyJanus kinase 2Myeloproliferative DisordersbiologyHaplotypefood and beveragesHematologyJanus Kinase 2Middle AgedOncologyHaplotypesMutation (genetic algorithm)MutationCancer researchbiology.proteinFemaleReceptors Thrombopoietinhormones hormone substitutes and hormone antagonists

description

MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2 V617F-negative myeloproliferative neoplasms

yearjournalcountryeditionlanguage
2010-01-28
http://hdl.handle.net/10447/55595